-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 Tt5VeIuGfpXzhKlQvOsISJfvh3jiTza106PNOD15AOyKORaEr0McWs8tbY9bC/Ba
 X/2ez7fq2txTYmCM9XHxLg==

<SEC-DOCUMENT>0000069499-03-000034.txt : 20030515
<SEC-HEADER>0000069499-03-000034.hdr.sgml : 20030515
<ACCEPTANCE-DATETIME>20030515153657
ACCESSION NUMBER:		0000069499-03-000034
CONFORMED SUBMISSION TYPE:	5
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20030331
FILED AS OF DATE:		20030515

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MYLAN LABORATORIES INC
		CENTRAL INDEX KEY:			0000069499
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				251211621
		STATE OF INCORPORATION:			PA
		FISCAL YEAR END:			0331

	BUSINESS ADDRESS:	
		STREET 1:		1500 CORPORATE DRIVE
		STREET 2:		SUITE 400
		CITY:			CANONSBURG
		STATE:			PA
		ZIP:			15317
		BUSINESS PHONE:		724-514-1800

	MAIL ADDRESS:	
		STREET 1:		1500 CORPORATE DRIVE
		STREET 2:		SUITE 400
		CITY:			CANONSBURG
		STATE:			PA
		ZIP:			15317

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FRM CORP
		DATE OF NAME CHANGE:	19711003

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			TODD C B
		CENTRAL INDEX KEY:			0001116509
		STATE OF INCORPORATION:			PA
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		5
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-09114
		FILM NUMBER:		03704721

	BUSINESS ADDRESS:	
		STREET 1:		467 LAKEVIEW MANOR DRIVE
		CITY:			MORGANTOWN
		STATE:			WV
		ZIP:			26508
		BUSINESS PHONE:		3045940652

	MAIL ADDRESS:	
		STREET 1:		467 LAKEVIEW MANOR DRIVE
		CITY:			MORGANTOWN
		STATE:			WV
		ZIP:			26508
</SEC-HEADER>
<DOCUMENT>
<TYPE>5
<SEQUENCE>1
<FILENAME>primary_doc.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>

<ownershipDocument>

    <documentType>5</documentType>

    <periodOfReport>2003-03-31</periodOfReport>


    <notSubjectToSection16>0</notSubjectToSection16>

    <form3HoldingsReported>0</form3HoldingsReported>

    <form4TransactionsReported>0</form4TransactionsReported>

    <issuer>
        <issuerCik>0000069499</issuerCik>
        <issuerName>MYLAN LABORATORIES INC</issuerName>
        <issuerTradingSymbol>MYL</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001116509</rptOwnerCik>
            <rptOwnerName>TODD C B</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>  </rptOwnerStreet1>
            <rptOwnerStreet2>  </rptOwnerStreet2>
            <rptOwnerCity>  </rptOwnerCity>
            <rptOwnerState>  </rptOwnerState>
            <rptOwnerZipCode>  </rptOwnerZipCode>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeSecurity>
        <securityTitle>
            <value>Mylan Laboratories Inc. Common Stock</value>
            <footnoteId id="F1"/>
        </securityTitle>
        <transactionDate>
            <value>2000-04-26</value>
        </transactionDate>
        <transactionCoding>
            <transactionFormType>5</transactionFormType>
            <transactionCode>G</transactionCode>
            <equitySwapInvolved>0</equitySwapInvolved>
        </transactionCoding>
        <transactionTimeliness>
            <value>L</value>
        </transactionTimeliness>
        <transactionAmounts>
            <transactionShares>
                <value>7508</value>
            </transactionShares>
            <transactionValue>
                <value>0</value>
            </transactionValue>
            <transactionAcquiredDisposedCode>
                <value>D</value>
            </transactionAcquiredDisposedCode>
        </transactionAmounts>
        <postTransactionAmounts>
            <sharesOwnedFollowingTransaction>
                <value>540499</value>
            </sharesOwnedFollowingTransaction>
        </postTransactionAmounts>
        <ownershipNature>
            <directOrIndirectOwnership>
                <value>D</value>
            </directOrIndirectOwnership>
        </ownershipNature>
    </nonDerivativeSecurity>

    <nonDerivativeSecurity>
        <securityTitle>
            <value>Mylan Laboratories Inc. Common Stock</value>
        </securityTitle>
        <transactionDate>
            <value>2002-04-15</value>
        </transactionDate>
        <transactionCoding>
            <transactionFormType>5</transactionFormType>
            <transactionCode>G</transactionCode>
            <equitySwapInvolved>0</equitySwapInvolved>
        </transactionCoding>
        <transactionTimeliness>
            <value></value>
        </transactionTimeliness>
        <transactionAmounts>
            <transactionShares>
                <value>45000</value>
            </transactionShares>
            <transactionValue>
                <value>0</value>
            </transactionValue>
            <transactionAcquiredDisposedCode>
                <value>D</value>
            </transactionAcquiredDisposedCode>
        </transactionAmounts>
        <postTransactionAmounts>
            <sharesOwnedFollowingTransaction>
                <value>495499</value>
            </sharesOwnedFollowingTransaction>
        </postTransactionAmounts>
        <ownershipNature>
            <directOrIndirectOwnership>
                <value>D</value>
            </directOrIndirectOwnership>
        </ownershipNature>
    </nonDerivativeSecurity>

    <nonDerivativeSecurity>
        <securityTitle>
            <value>Mylan Laboratories Inc. Common Stock</value>
        </securityTitle>
        <transactionDate>
            <value>2002-12-23</value>
        </transactionDate>
        <transactionCoding>
            <transactionFormType>5</transactionFormType>
            <transactionCode>G</transactionCode>
            <equitySwapInvolved>0</equitySwapInvolved>
        </transactionCoding>
        <transactionTimeliness>
            <value></value>
        </transactionTimeliness>
        <transactionAmounts>
            <transactionShares>
                <value>7500</value>
            </transactionShares>
            <transactionValue>
                <value>0</value>
            </transactionValue>
            <transactionAcquiredDisposedCode>
                <value>D</value>
            </transactionAcquiredDisposedCode>
        </transactionAmounts>
        <postTransactionAmounts>
            <sharesOwnedFollowingTransaction>
                <value>487999</value>
                <footnoteId id="F2"/>
            </sharesOwnedFollowingTransaction>
        </postTransactionAmounts>
        <ownershipNature>
            <directOrIndirectOwnership>
                <value>D</value>
            </directOrIndirectOwnership>
        </ownershipNature>
    </nonDerivativeSecurity>

    <footnotes>
        <footnote id="F1">This April 2000 gift of stock, 5,000 shares pre-split, should have been reported on the May 2001 Form 5, but was inadvertently missed due to an administrative oversight.</footnote>
        <footnote id="F2">March 31, 2003, 12,121 shares of Mylan Stock were transferred from Mr. Todd's 401(k) Plan into direct ownership. This brings the total of Mr. Todd's securities beneficially owned to 500,120.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>C.B. Todd</signatureName>
        <signatureDate>2003-05-15</signatureDate>
    </ownerSignature>

</ownershipDocument>

</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----